Celcuity Inc (CELC.OQ)
CELC.OQ on NASDAQ Stock Exchange Capital Market
17.41USD
20 Apr 2018
17.41USD
20 Apr 2018
Change (% chg)
$0.46 (+2.71%)
$0.46 (+2.71%)
Prev Close
$16.95
$16.95
Open
$16.79
$16.79
Day's High
$17.55
$17.55
Day's Low
$16.79
$16.79
Volume
3,311
3,311
Avg. Vol
8,177
8,177
52-wk High
$22.13
$22.13
52-wk Low
$11.10
$11.10
About
Celcuity, Inc. is a cellular analysis company. The Company is focused on discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The Company’s proprietary CELx diagnostic platform uses a patient’s living... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | $126.97 |
| Shares Outstanding(Mil.): | 9.72 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CELC.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 84.02 | 32.74 |
| EPS (TTM): | -0.48 | -- | -- |
| ROI: | -- | 1.58 | 14.38 |
| ROE: | -- | 2.41 | 16.07 |
BRIEF-Celcuity Reports Q4 Adjusted Non-Gaap Loss Per Share $0.14
* CELCUITY REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS
BRIEF-Celcuity reports Q3 loss $0.26/shr
* Celcuity reports third quarter fiscal 2017 financial results
Estimates